|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-7-7
|
|
pubmed:abstractText |
Clevudine is an effective antiviral nucleoside analogue, but there are few data regarding its long-term effects, resistance, and safety. The aim of this study was to evaluate the long-term clinical efficacy of clevudine over a 1-year treatment period in nucleos(t)ide-naive and lamivudine-experienced chronic hepatitis B patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
kor
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1738-222X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
179-92
|
|
pubmed:meshHeading |
pubmed-meshheading:19581770-Adult,
pubmed-meshheading:19581770-Aged,
pubmed-meshheading:19581770-Aged, 80 and over,
pubmed-meshheading:19581770-Antiviral Agents,
pubmed-meshheading:19581770-Arabinofuranosyluracil,
pubmed-meshheading:19581770-DNA, Viral,
pubmed-meshheading:19581770-Drug Resistance, Viral,
pubmed-meshheading:19581770-Female,
pubmed-meshheading:19581770-Genotype,
pubmed-meshheading:19581770-Hepatitis B, Chronic,
pubmed-meshheading:19581770-Hepatitis B Surface Antigens,
pubmed-meshheading:19581770-Hepatitis B e Antigens,
pubmed-meshheading:19581770-Humans,
pubmed-meshheading:19581770-Lamivudine,
pubmed-meshheading:19581770-Male,
pubmed-meshheading:19581770-Middle Aged,
pubmed-meshheading:19581770-Mutation,
pubmed-meshheading:19581770-RNA-Directed DNA Polymerase
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
[Long-term clevudine therapy in nucleos(t)ide-naïve and lamivudine-experienced patients with hepatitis B virus-related chronic liver diseases].
|
|
pubmed:affiliation |
Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea. hjlee@med.yu.ac.kr
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Controlled Clinical Trial
|
